NCT05046444 - Solving Riddles Through Sequencing | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

October 1, 2026

Conditions

LeukemiaHematologic MalignancyRare DiseasesRefractory LeukemiaRefractory LymphomaUnknown Primary Tumors

Interventions

DIAGNOSTIC_TEST

Next Generation Sequencing

NON-Interventional Observation only study comparing sequencing-only approaches to classical diagnostic methods

Trial Locations (1)

RECRUITING

MLL Munich Leukemia Laboratory, Munich